New insights of engineering plant exosome-like nanovesicles as a nanoplatform for therapeutics and drug delivery
2022

Engineering Plant Exosome-like Nanovesicles for Drug Delivery

publication Evidence: moderate

Author Information

Author(s): Shinge Shafiu A. Umar, Xiao Yin, Xia Jiang, Liang Yujie, Duan Li

Primary Institution: The First Affiliated Hospital of Shenzhen University

Hypothesis

Can plant exosome-like nanovesicles (PELNVs) be engineered to improve their effectiveness as therapeutic and drug delivery platforms?

Conclusion

Plant exosome-like nanovesicles (PELNVs) show great potential as biocompatible and effective carriers for drug delivery due to their unique properties.

Supporting Evidence

  • PELNVs are biocompatible and biodegradable, making them suitable for therapeutic applications.
  • PELNVs can carry various therapeutic agents, including siRNAs and proteins, to target tissues.
  • Engineering PELNVs can enhance their drug delivery efficiency and targeting capabilities.

Takeaway

Scientists are exploring tiny particles from plants that can carry medicine to help treat diseases without harming the body.

Methodology

This review discusses the roles of PELNVs in physiology and pathology and explores engineering approaches for their use in drug delivery.

Limitations

The understanding of the molecular and cellular mechanisms behind PELNVs' bio-functions is still limited.

Digital Object Identifier (DOI)

10.20517/evcna.2021.25

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication